Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram.
A term neonate presenting with necrotizing enterocolitis following in utero and breast milk exposure to the newest serotonin selective reuptake inhibitor, escitalopram, is described.
Potts
A L
AL
Department of Pharmacy, Vanderbilt Children's Hospital, Nashville, TN 37232-9544, USA.
Young
K L
KL
Carter
B S
BS
Shenai
J P
JP
D015283:Citalopram / Q000009:adverse effects* / Q000627:therapeutic use; D020345:Enterocolitis, Necrotizing / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008895:Milk, Human / Q000187:drug effects*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors